ANDLAUER HEALTHCARE GROUP IN (AND.CA) Stock Fundamental Analysis
TSX:AND - Toronto Stock Exchange - CA0342231077 - Common Stock - Currency: CAD
AND gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 15 industry peers in the Health Care Providers & Services industry. AND scores excellent points on both the profitability and health parts. This is a solid base for a good stock. AND has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year AND was profitable.
In the past year AND had a positive cash flow from operations.
AND had positive earnings in each of the past 5 years.
Each year in the past 5 years AND had a positive operating cash flow.
1.2 Ratios
AND's Return On Assets of 9.83% is fine compared to the rest of the industry. AND outperforms 80.00% of its industry peers.
AND has a Return On Equity of 15.77%. This is amongst the best in the industry. AND outperforms 86.67% of its industry peers.
The Return On Invested Capital of AND (11.91%) is better than 86.67% of its industry peers.
AND had an Average Return On Invested Capital over the past 3 years of 11.97%. This is above the industry average of 8.13%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.83% | ||
| ROE | 15.77% | ||
| ROIC | 11.91% |
ROA(3y)9.88%
ROA(5y)11.71%
ROE(3y)15.44%
ROE(5y)22.37%
ROIC(3y)11.97%
ROIC(5y)12.76%
1.3 Margins
AND has a better Profit Margin (10.69%) than 86.67% of its industry peers.
AND's Profit Margin has been stable in the last couple of years.
AND has a Operating Margin of 14.36%. This is amongst the best in the industry. AND outperforms 86.67% of its industry peers.
In the last couple of years the Operating Margin of AND has remained more or less at the same level.
AND has a worse Gross Margin (33.63%) than 60.00% of its industry peers.
AND's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.36% | ||
| PM (TTM) | 10.69% | ||
| GM | 33.63% |
OM growth 3Y-4.81%
OM growth 5Y-1.42%
PM growth 3Y-21.44%
PM growth 5Y-0.72%
GM growth 3Y-14.76%
GM growth 5Y-10.42%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so AND is still creating some value.
The number of shares outstanding for AND has been reduced compared to 1 year ago.
The number of shares outstanding for AND has been increased compared to 5 years ago.
Compared to 1 year ago, AND has a worse debt to assets ratio.
2.2 Solvency
An Altman-Z score of 5.52 indicates that AND is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 5.52, AND belongs to the top of the industry, outperforming 93.33% of the companies in the same industry.
The Debt to FCF ratio of AND is 1.74, which is an excellent value as it means it would take AND, only 1.74 years of fcf income to pay off all of its debts.
AND's Debt to FCF ratio of 1.74 is amongst the best of the industry. AND outperforms 93.33% of its industry peers.
A Debt/Equity ratio of 0.21 indicates that AND is not too dependend on debt financing.
AND has a Debt to Equity ratio of 0.21. This is amongst the best in the industry. AND outperforms 86.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.21 | ||
| Debt/FCF | 1.74 | ||
| Altman-Z | 5.52 |
ROIC/WACC1.54
WACC7.72%
2.3 Liquidity
A Current Ratio of 1.26 indicates that AND should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.26, AND belongs to the top of the industry, outperforming 93.33% of the companies in the same industry.
AND has a Quick Ratio of 1.22. This is a normal value and indicates that AND is financially healthy and should not expect problems in meeting its short term obligations.
AND has a Quick ratio of 1.22. This is amongst the best in the industry. AND outperforms 93.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.26 | ||
| Quick Ratio | 1.22 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 5.26% over the past year.
AND shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 14.82% yearly.
The Revenue has been growing slightly by 1.72% in the past year.
AND shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 17.53% yearly.
EPS 1Y (TTM)5.26%
EPS 3Y-10.45%
EPS 5Y14.82%
EPS Q2Q%5.71%
Revenue 1Y (TTM)1.72%
Revenue growth 3Y13.91%
Revenue growth 5Y17.53%
Sales Q2Q%3.07%
3.2 Future
AND is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.89% yearly.
Based on estimates for the next years, AND will show a small growth in Revenue. The Revenue will grow by 3.25% on average per year.
EPS Next Y13.36%
EPS Next 2Y12.5%
EPS Next 3Y8.89%
EPS Next 5YN/A
Revenue Next Year3.66%
Revenue Next 2Y3.99%
Revenue Next 3Y3.25%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 33.08 indicates a quite expensive valuation of AND.
AND's Price/Earnings ratio is a bit cheaper when compared to the industry. AND is cheaper than 66.67% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.03, AND is valued a bit more expensive.
Based on the Price/Forward Earnings ratio of 26.47, the valuation of AND can be described as expensive.
Based on the Price/Forward Earnings ratio, AND is valued a bit cheaper than the industry average as 73.33% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 36.28, AND is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 33.08 | ||
| Fwd PE | 26.47 |
4.2 Price Multiples
66.67% of the companies in the same industry are more expensive than AND, based on the Enterprise Value to EBITDA ratio.
AND's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. AND is cheaper than 66.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 19.75 | ||
| EV/EBITDA | 13.4 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
AND has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)2.48
PEG (5Y)2.23
EPS Next 2Y12.5%
EPS Next 3Y8.89%
5. Dividend
5.1 Amount
With a yearly dividend of 0.91%, AND is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 3.38, AND pays a bit more dividend than its industry peers.
With a Dividend Yield of 0.91, AND pays less dividend than the S&P500 average, which is at 2.40.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.91% |
5.2 History
The dividend of AND decreases each year by -34.89%.
AND has been paying a dividend for over 5 years, so it has already some track record.
AND has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-34.89%
Div Incr Years3
Div Non Decr Years3
5.3 Sustainability
AND pays out 24.69% of its income as dividend. This is a sustainable payout ratio.
DP24.69%
EPS Next 2Y12.5%
EPS Next 3Y8.89%
TSX:AND (8/5/2025, 7:00:00 PM)
52.93
-0.02 (-0.04%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners64.65%
Inst Owner ChangeN/A
Ins Owners2.37%
Ins Owner ChangeN/A
Market Cap2.07B
Analysts50
Price Target56.92 (7.54%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.91% |
Yearly Dividend0.42
Dividend Growth(5Y)-34.89%
DP24.69%
Div Incr Years3
Div Non Decr Years3
Ex-Date
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-7.97%
Min EPS beat(2)-10.65%
Max EPS beat(2)-5.29%
EPS beat(4)0
Avg EPS beat(4)-5.72%
Min EPS beat(4)-10.65%
Max EPS beat(4)-0.99%
EPS beat(8)1
Avg EPS beat(8)-7.81%
EPS beat(12)4
Avg EPS beat(12)-2.16%
EPS beat(16)6
Avg EPS beat(16)12.76%
Revenue beat(2)0
Avg Revenue beat(2)-1.99%
Min Revenue beat(2)-2.12%
Max Revenue beat(2)-1.87%
Revenue beat(4)0
Avg Revenue beat(4)-2.27%
Min Revenue beat(4)-3.14%
Max Revenue beat(4)-1.87%
Revenue beat(8)1
Avg Revenue beat(8)-3.09%
Revenue beat(12)5
Avg Revenue beat(12)-0.11%
Revenue beat(16)8
Avg Revenue beat(16)0.85%
PT rev (1m)0%
PT rev (3m)15.05%
EPS NQ rev (1m)0.8%
EPS NQ rev (3m)-0.47%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0.47%
Revenue NQ rev (3m)-0.64%
Revenue NY rev (1m)-0.28%
Revenue NY rev (3m)-0.6%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 33.08 | ||
| Fwd PE | 26.47 | ||
| P/S | 3.16 | ||
| P/FCF | 19.75 | ||
| P/OCF | 16.65 | ||
| P/B | 4.67 | ||
| P/tB | 17.85 | ||
| EV/EBITDA | 13.4 |
EPS(TTM)1.6
EY3.02%
EPS(NY)2
Fwd EY3.78%
FCF(TTM)2.68
FCFY5.06%
OCF(TTM)3.18
OCFY6.01%
SpS16.74
BVpS11.34
TBVpS2.97
PEG (NY)2.48
PEG (5Y)2.23
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.83% | ||
| ROE | 15.77% | ||
| ROCE | 16.31% | ||
| ROIC | 11.91% | ||
| ROICexc | 12.9% | ||
| ROICexgc | 33.53% | ||
| OM | 14.36% | ||
| PM (TTM) | 10.69% | ||
| GM | 33.63% | ||
| FCFM | 16.01% |
ROA(3y)9.88%
ROA(5y)11.71%
ROE(3y)15.44%
ROE(5y)22.37%
ROIC(3y)11.97%
ROIC(5y)12.76%
ROICexc(3y)12.48%
ROICexc(5y)13.78%
ROICexgc(3y)30.54%
ROICexgc(5y)29.2%
ROCE(3y)16.39%
ROCE(5y)17.47%
ROICexcg growth 3Y-1.36%
ROICexcg growth 5Y-1.14%
ROICexc growth 3Y4.48%
ROICexc growth 5Y-13.43%
OM growth 3Y-4.81%
OM growth 5Y-1.42%
PM growth 3Y-21.44%
PM growth 5Y-0.72%
GM growth 3Y-14.76%
GM growth 5Y-10.42%
F-Score5
Asset Turnover0.92
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.21 | ||
| Debt/FCF | 1.74 | ||
| Debt/EBITDA | 0.58 | ||
| Cap/Depr | 27.56% | ||
| Cap/Sales | 2.98% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 75.43% | ||
| Profit Quality | 149.79% | ||
| Current Ratio | 1.26 | ||
| Quick Ratio | 1.22 | ||
| Altman-Z | 5.52 |
F-Score5
WACC7.72%
ROIC/WACC1.54
Cap/Depr(3y)36.55%
Cap/Depr(5y)30.34%
Cap/Sales(3y)3.8%
Cap/Sales(5y)3.06%
Profit Quality(3y)141.22%
Profit Quality(5y)125.45%
High Growth Momentum
Growth
EPS 1Y (TTM)5.26%
EPS 3Y-10.45%
EPS 5Y14.82%
EPS Q2Q%5.71%
EPS Next Y13.36%
EPS Next 2Y12.5%
EPS Next 3Y8.89%
EPS Next 5YN/A
Revenue 1Y (TTM)1.72%
Revenue growth 3Y13.91%
Revenue growth 5Y17.53%
Sales Q2Q%3.07%
Revenue Next Year3.66%
Revenue Next 2Y3.99%
Revenue Next 3Y3.25%
Revenue Next 5YN/A
EBIT growth 1Y0.8%
EBIT growth 3Y8.43%
EBIT growth 5Y15.86%
EBIT Next Year82.63%
EBIT Next 3Y25.61%
EBIT Next 5YN/A
FCF growth 1Y2.64%
FCF growth 3Y11.81%
FCF growth 5Y13.66%
OCF growth 1Y-5.87%
OCF growth 3Y13.94%
OCF growth 5Y15.32%